Brief: Freenome And Perceptive Capital Solutions Corp Announce Business Combination Agreement
05/12/2025 13:34
Dec 5 (Reuters) - Perceptive Capital Solutions Corp PCSC.O: FREENOME AND PERCEPTIVE CAPITAL SOLUTIONS CORP ANNOUNCE BUSINESS COMBINATION AGREEMENT TO CREATE A PUBLICLY LISTED COMPANY TRANSFORMING BLOOD-BASED MULTI-CANCER DETECTION THROUGH AN AI/ML-ENABLED MULTIOMICS PLATFORM PERCEPTIVE CAPITAL SOLUTIONS CORP - INSTITUTIONAL INVESTORS COMMIT $240 MILLION THROUGH PIPE PERCEPTIVE CAPITAL SOLUTIONS CORP - COMBINED COMPANY TO BE LISTED ON NASDAQ UNDER TICKER FRNM PERCEPTIVE CAPITAL SOLUTIONS CORP - PCSC TO REDOMICILE AS DELAWARE CORPORATION, RENAMED FREENOME, INC. Source text: ID:nPn1Jf9wWa Further company coverage: PCSC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Freenome
See all newsBrief: Freenome Expands Personalized Cancer Detection Portfolio With Simplescreen Lung Test
FDA approves Freenome's blood test for colorectal cancer screening (updated)
FDA approves Freenome's blood test for colorectal cancer screening
Brief: FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott To Commercialize In The U.S.
Brief: Freenome And Perceptive Capital Solutions Corp Announce Business Combination Agreement